Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis
- DOI
- 10.1002/ppul.71749
- Published
- 2026-07-28
- Container
- Pediatric Pulmonology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ppul.71749,
title = {Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis},
author = {Julianne Fava and Emily Stephan and Jessica Tansmore and Shahid Sheikh and Mariah Eisner and Kimberly J. Novak},
year = {2026},
journal = {Pediatric Pulmonology},
doi = {10.1002/ppul.71749},
url = {https://doi.org/10.1002/ppul.71749}
}RIS
TY - JOUR TI - Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis AU - Julianne Fava AU - Emily Stephan AU - Jessica Tansmore AU - Shahid Sheikh AU - Mariah Eisner AU - Kimberly J. Novak PY - 2026 JO - Pediatric Pulmonology DO - 10.1002/ppul.71749 UR - https://doi.org/10.1002/ppul.71749 ER -
APA
Fava, J., Stephan, E., Tansmore, J., Sheikh, S., Eisner, M., & Novak, K. J. (2026). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71749
Source records
- crossref · retrieved 2026-09-25T12:50:56.954Z